Skip to main content

CITADEL ADVISORS LLC

Position in SKYE — Skye Bioscience, Inc.

CIK 1423053 MIAMI, FL

Position in SKYE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
7 quarters on record

Common Shares in SKYE Over Time

Shares Held

Position Value (USD)

Derivatives in SKYE

reported options exposure · as of Mar 31, 2026
CallValue
$24,046
CallShares
39,100
PutValue
$36,777
PutShares
59,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in SKYE

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $24,046 39,100
2026-03-31 $36,777 59,800
2025-12-31 $48,525 64,700
2025-12-31 $13,500 18,000
2025-09-30 $110,826 28,200
2025-09-30 $113,388 28,852
2025-06-30 $139,612 33,400
2025-06-30 $69,806 16,700
2024-12-31 $707,538 250,014
2024-12-31 $283 100
2024-09-30 $59,432 15,200
2024-09-30 $31,671 8,100
2024-09-30 $977,550 250,013
2024-06-30 $8,811 1,100
2024-06-30 $2,127,351 265,587
2024-06-30 $8,811 1,100